ArticleMedical & biological engineering & computing2022
Improving the generalization of unsupervised feature learning by using data from different sources on gene expression data for cancer diagnosis.
Article in Medical & biological engineering & computing, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 2 citations in OpenAlex.
- Deep learning identifies TP-41 for methylglyoxal scavenging in Alzheimer's treatment.Theranostics · 2026Article
- RN-Autoencoder: Reduced Noise Autoencoder for classifying imbalanced cancer genomic data.Journal of biological engineering · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 2 countries.
Funding
Abstract
Machine learning techniques have been utilized on gene expression profiling for cancer diagnosis. However, the gene expression data suffer from the curse of high dimensionality. Different kinds of feature reduction methods have been proposed to decrease the features for specific cancer diagnosis. However, with the difficulty of obtaining the samples of a particular tumor, the lack of training samples may lead to the overfitting problem. In addition, the feature reduction model on a specific tumor may lead to the problem that the model is not scalable and cannot be generalized to new cancer types. To handle these problems, this paper proposes an unsupervised feature learning method to reduce the data dimensionality of gene expression data. This method amplifies the training samples of feature learning by utilizing the unlabeled samples from different sources. Two heuristic rules are devised to check if the unlabeled samples could be used for amplifying the training set. The amplified training set is used to train the feature learning model based on sparse autoencoder. Since the method leverages the knowledge among the expression data from different sources, it improves the generalization of unsupervised feature learning and further boosts the cancer diagnosis performance. A series of experiments are carried out on the gene expression datasets from TCGA and other sources. Experimental results prove that our method improves the generalization of cancer diagnosis when unlabeled data are used for latent feature learning. The flowchart of our proposed feature learning method.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.